Search

Search bills, members, committees and pages...

KATHERINE LANDES

41 federal lobbying filings, 2023 to 2026.

KATHERINE LANDES is a registered lobbyist named on 41 federal lobbying filings, 2023 to 2026, reporting $840K across them.

An LDA filing reports one registrant’s income from one client for everything they worked that quarter, so a total here is the sum of whole filings and never a price for one issue or one bill.


Firms

2 they have filed under, by filings.

RegistrantFilingsReported
THE KPM GROUP DC LLC32$840K
STEALTH BIOTHERAPEUTICS INC.9

By year

Filings and what they reported, newest year first.

YearFilingsIncomeExpenses
20262$240K
20254$380K
20243$80K
202332$840K

Issues

The LDA issue codes the filings were filed under.

CodeIssueFilings
HCRHealth Issues25
PHAPharmacy18

Bills

The bills the filings name, by how many name them.

BillTitleFilings
H.R. 1262Mikaela Naylon Give Kids a Chance Act6
H.R. 1532Scientific EXPERT Act of 20256
S. 822Scientific EXPERT Act of 20256
S. 932Give Kids a Chance Act of 20256
H.R. 4121Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 20265
S. 2256Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 20265
H.R. 1092Responsible Budgeting Act3
H.R. 1509Accelerating Kids’ Access to Care Act of 20253
H.R. 7384Preventing Mass Casualties from Release of Hydrofluoric Acid at Refineries Act of 20263
S. 4583Legalizing Premium Health Care Act of 20263
S. 526Pharmacy Benefit Manager Transparency Act of 20253
S. 752Accelerating Kids’ Access to Care Act3
H.R. 1An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.2
H.R. 4709Newborn Screening Saves Lives Reauthorization Act of 20252
H.R. 6280Access to Genetic Counselor Services Act of 20252
H.R. 946ORPHAN Cures Act2
S. 1862ORPHAN Cures Act2
S. 3607Access to Genetic Counselor Services Act of 20262

Filings

The documents themselves, on the Senate’s Lobbying Disclosure site, newest first.

ClientRegistrantPeriodReportedPosted
STEALTH BIOTHERAPEUTICS INC.STEALTH BIOTHERAPEUTICS INC.2026 second_quarter$120KJul 20, 2026
STEALTH BIOTHERAPEUTICS INC.STEALTH BIOTHERAPEUTICS INC.2026 first_quarter$120KApr 20, 2026
STEALTH BIOTHERAPEUTICS INC.STEALTH BIOTHERAPEUTICS INC.2025 fourth_quarter$110KJan 20, 2026
STEALTH BIOTHERAPEUTICS INC.STEALTH BIOTHERAPEUTICS INC.2025 third_quarter$110KOct 20, 2025
STEALTH BIOTHERAPEUTICS INC.STEALTH BIOTHERAPEUTICS INC.2025 second_quarter$110KJul 21, 2025
STEALTH BIOTHERAPEUTICS INC.STEALTH BIOTHERAPEUTICS INC.2025 first_quarter$50KApr 22, 2025
STEALTH BIOTHERAPEUTICS INC.STEALTH BIOTHERAPEUTICS INC.2024 fourth_quarter$40KJan 21, 2025
STEALTH BIOTHERAPEUTICS INC.STEALTH BIOTHERAPEUTICS INC.2024 third_quarter$40KOct 22, 2024
STEALTH BIOTHERAPEUTICS INC.STEALTH BIOTHERAPEUTICS INC.2024 third_quarterOct 11, 2024
STEALTH BIOTHERAPEUTICS INC.THE KPM GROUP DC LLC2023 fourth_quarter$20KJan 22, 2024
SOLENO THERAPEUTICS, INC.THE KPM GROUP DC LLC2023 fourth_quarter$40KJan 22, 2024
REZOLUTETHE KPM GROUP DC LLC2023 fourth_quarter$20KJan 22, 2024
RARE DISEASE COMPANY COALITIONTHE KPM GROUP DC LLC2023 fourth_quarter$60KJan 22, 2024
CHIESI USA, INC.THE KPM GROUP DC LLC2023 fourth_quarter$30KJan 22, 2024
THE BRAIN DONOR PROJECTTHE KPM GROUP DC LLC2023 fourth_quarter$10KJan 22, 2024
ASTRIA THERAPEUTICS, INC.THE KPM GROUP DC LLC2023 fourth_quarter$40KJan 22, 2024
REZOLUTETHE KPM GROUP DC LLC2023 third_quarter$20KOct 20, 2023
SOLENO THERAPEUTICS, INC.THE KPM GROUP DC LLC2023 third_quarter$40KOct 20, 2023
STEALTH BIOTHERAPEUTICS INC.THE KPM GROUP DC LLC2023 third_quarter$20KOct 20, 2023
FULCRUM THERAPEUTICS, INC.THE KPM GROUP DC LLC2023 third_quarter$30KOct 20, 2023
RARE DISEASE COMPANY COALITIONTHE KPM GROUP DC LLC2023 third_quarter$60KOct 20, 2023
THE BRAIN DONOR PROJECTTHE KPM GROUP DC LLC2023 third_quarter$10KOct 20, 2023
CHIESI USA, INC.THE KPM GROUP DC LLC2023 third_quarter$30KOct 20, 2023
ASTRIA THERAPEUTICS, INC.THE KPM GROUP DC LLC2023 third_quarterSep 27, 2023
REZOLUTETHE KPM GROUP DC LLC2023 third_quarterAug 3, 2023